SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "LAR1:gu ;srt2:(2004);lar1:(liu)"

Sökning: LAR1:gu > (2004) > Linköpings universitet

  • Resultat 1-10 av 67
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Aittomaki, K, et al. (författare)
  • Safety issues in assisted reproduction technology: should ICSI patients have genetic testing before treatment? A practical proposition to help patient information
  • 2004
  • Ingår i: Hum Reprod. - : Oxford University Press (OUP). ; 19:3, s. 472-476
  • Tidskriftsartikel (refereegranskat)abstract
    • ICSI is a highly efficient treatment of male factor infertility and therefore increasingly used to treat infertile men successfully. However, when used to treat patients with a genetic cause for their infertility, there may be an increased risk for the offspring. Chromosome aberrations, Y chromosome microdeletions and CFTR (cystic fibrosis transmembrane conductance regulator) mutations alone may explain up to 25% of azoospermia and severe oligozoospermia. These genetic defects could be identified before treatment, in which case informed decisions could be made by the couple to be treated concerning the treatment, prenatal testing or preimplantation genetic diagnosis. Therefore, we propose that men with very low sperm counts (<5 x 10(6)/ml) considering ICSI should always be informed of the possibility of genetic testing. The information should include a precise statement of the implications of the results for the patient, his family and his offspring, and reassurance that a decision to test or not to test, or the subsequent test results will not be used as a reason for withholding treatment. Testing should always remain voluntary, and the couples themselves should decide whether or not they choose to be tested. If an abnormality is identified, patients should be referred to specialist genetic counselling.
  •  
2.
  • Altimiras, Jordi, 1967-, et al. (författare)
  • Intrinsic autoregulation of cardiac output in rainbow trout (Oncorhynchus mykiss) at different heart rates
  • 2004
  • Ingår i: J Exp Biol. - : The Company of Biologists. ; 207:Pt 2, s. 195-201
  • Tidskriftsartikel (refereegranskat)abstract
    • Intrinsic regulation of the heart in teleosts is partly driven by central venous pressure, which exerts a modulatory role on stroke volume according to the well-known Frank-Starling mechanism. Although this mechanism is well understood from heart perfusion studies, less is known about how this mechanism operates in vivo, where heart rate varies markedly. We used zatebradine, a bradycardic agent, to attain resting heart rates in surgically instrumented animals. A dose of zatebradine of 2.79+/-0.47 mg l(-1) decreased heart rate by half, from 44.4+/-4.19 beats min(-1) to 22.1+/-1.9 beats min(-1). Zatebradine had no significant effect on the peripheral vasculature and no inotropic effects, so was a suitable pharmacological agent with which to manipulate heart rate. When heart rate halved, cardiac output dropped to 87.5+/-4.6% of the control value, due to the concomitant increase in stroke volume to 165+/-13%. In vivo recordings of venous pressure at varying heart rates indicated that the partial compensation in cardiac output was possible through an increase in pressure in the sinus venosus, from -0.06+/-0.04 kPa at a control heart rate of 58.3+/-3.5 beats min(-1) (N=10) to 0.07+/-0.05 kPa after injection of zatebradine (4 mg kg(-1)). The operation of the so-called time-dependent autoregulatory mechanism was further demonstrated in perfused hearts. The positive pressures recorded in the sinus venosus at low heart rates coincident with non-invasive measurements in trout suggest that atrial filling in trout is more dependent on the build-up of pressure in the venous circulation (vis-a-tergo filling) than a suction mechanism during ventricular contraction (vis-a-fronte filling).
  •  
3.
  •  
4.
  •  
5.
  • Andius, Patrik, 1963, et al. (författare)
  • Prognostic factors in patients with carcinoma in situ treated with intravesical bacille Calmette-Guérin.
  • 2004
  • Ingår i: Scand J Urol Nephrol. - : Informa UK Limited. ; 38:4, s. 285-290
  • Tidskriftsartikel (refereegranskat)abstract
    • Abstract Objective: To report prognostic factors and follow-up data for an unselected group of patients with carcinoma in situ (CIS) of the urinary bladder treated with bacille Calmette-Guérin (BCG). Material and Methods: The clinical records of patients with CIS treated with BCG were reviewed. All 173 patients treated between 1986 and 1997 in four hospitals in two Swedish cities were included. The median follow-up period was 72 months (range 6-154 months). The impact of 18 variables on the times to recurrence and progression was studied using multivariate Cox proportional hazard regression and Kaplan-Meier analyses. Results: No pre-treatment variables, including type of CIS and T1G3 tumour, had prognostic value in terms of time to progression. The result of the first cystoscopy had a very strong prognostic importance: 44% of patients with a positive first cystoscopy progressed in stage, 59% were BCG failures and 35% died from urothelial cancer. The corresponding values for patients with a negative first cystoscopy were 11%, 18% and 8%. Fourteen patients (8%) were diagnosed with an upper urinary tract tumour but no variable had prognostic significance. The diagnoses of the upper urinary tract tumours were evenly distributed during follow-up. Conclusions: We were not able to predict which patients would respond favourably to BCG. Cystectomy should be strongly considered even after a positive first cystoscopy. The accumulated incidence of patients with bladder CIS and a subsequent upper urinary tract tumour is rather high but it is questionable whether the prognosis will improve if routine follow-up urographies are performed.
  •  
6.
  • Bauer, H C, et al. (författare)
  • The Scandinavian Sarcoma Group Register 1986-2001.
  • 2004
  • Ingår i: Acta orthopaedica Scandinavica. Supplementum. - : Medical Journals Sweden AB. - 0300-8827 .- 0001-6470. ; 75:Supplement 311, s. 8-10
  • Tidskriftsartikel (refereegranskat)
  •  
7.
  • Benson, Mikael, 1954, et al. (författare)
  • Altered levels of the soluble IL-1, IL-4 and TNF receptors, as well as the IL-1 receptor antagonist, in intermittent allergic rhinitis
  • 2004
  • Ingår i: Int Arch Allergy Immunol. - : S. Karger AG. - 1018-2438 .- 1423-0097. ; 134:3, s. 227-32
  • Tidskriftsartikel (refereegranskat)abstract
    • BACKGROUND: The effects of cytokines are modulated by soluble cytokine receptors (SCR) and receptor antagonists. Therefore, allergic disease may depend on altered proportions between cytokines, their SCR and receptor antagonists, rather than absolute changes in cytokine levels. Little is known about SCR in intermittent allergic rhinitis (IAR). OBJECTIVE: To examine the concentrations of SCR, i.e. sIL-1R2, sIL-4R, sIL-6R and sTNFR1, as well as the interleukin-1 receptor antagonist (IL-1Ra) in nasal fluids from allergen-challenged patients with IAR and healthy controls. METHODS: 30 patients with birch- or grass-pollen-induced IAR and 30 healthy controls were studied. In the patients nasal fluids were obtained before as well as 1 and 6 h after allergen provocation. RESULTS: Both symptom scores and rhinoscopic signs of rhinitis increased in the patients after allergen challenge. Comparisons between patients and controls showed that sIL-4R was lower in patients before and 1 and 6 h after provocation. IL-1Ra was lower before and 1 h after provocation. In addition, lower concentrations of sTNFR1 were found in patients after 1 h, while sIL-1R2 concentrations were higher after 1 h. Comparisons of patients before and after challenge showed that IL-1Ra and sTNFR1 decreased after 1 h, while sIL-1R2 increased. No significant differences were found compared to 6 h. sIL-6R did not significantly differ between the study groups. CONCLUSIONS: After allergen challenge, significant changes in the nasal fluid levels of IL-1Ra, sIL-1R2 and sTNFR1 were found. By contrast, sIL-4R remained at lower levels than in controls both before and after challenge. Since sIL-4R modulates IgE synthesis, this may play a role in the pathogenesis of IAR.
  •  
8.
  • Benson, Mikael, 1954, et al. (författare)
  • Gene profiling reveals increased expression of uteroglobin and other anti-inflammatory genes in glucocorticoid-treated nasal polyps.
  • 2004
  • Ingår i: Journal of Allergy and Clinical Immunology. - : Elsevier BV. - 0091-6749 .- 1097-6825. ; 113:6, s. 1137-43
  • Tidskriftsartikel (refereegranskat)abstract
    • BACKGROUND: Treatment with local glucocorticoids (GCs) decreases symptoms and the size of nasal polyps. This might depend on the downregulation of proinflammatory genes, as well as the upregulation of anti-inflammatory genes. OBJECTIVE: We sought to identify GC-regulated anti-inflammatory genes in nasal polyps. METHODS: Affymetrix DNA microarrays were used to analyze the expression of 22,283 genes in 4 nasal polyps before and after local treatment with fluticasone (400 microg/d). Expression of uteroglobin and mammaglobin B was analyzed with real-time PCR in 6 nasal polyps and in nasal biopsy specimens from 6 healthy control subjects. RESULTS: Two hundred three genes had changed in expression in treated polyps, and 139 had known functions: 54 genes were downregulated, and 85 were upregulated. Genes associated with inflammation constituted the largest single functional group. These genes affected key steps in inflammation (eg, immunoglobulin production; antigen processing and presentation; and the chemoattraction and activation of granulocytes, T cells, and B cells). Several proinflammatory genes were downregulated. In contrast, some anti-inflammatory genes were upregulated. The gene that increased most in terms of expression was uteroglobin. This was confirmed with real-time PCR. By contrast, expression of uteroglobin was lower in untreated polyps than in healthy nasal mucosa. Immunohistochemical investigation showed staining of uteroglobin in the epithelium and in seromucous glands in control subjects and in nasal polyps. CONCLUSION: Upregulation of anti-inflammatory genes, such as uteroglobin, might contribute to the effects of local treatment with GCs in nasal polyps.
  •  
9.
  •  
10.
  • Bergström, Anders, 1960-, et al. (författare)
  • Effect of carvedilol on diastolic function in patients with diastolic heart failure and preserved systolic function. Results of the Swedish Doppler-echocardiographic study (SWEDIC)
  • 2004
  • Ingår i: Eur J Heart Fail. - : Wiley. - 1388-9842 .- 1879-0844. ; 6:4, s. 453-61
  • Tidskriftsartikel (refereegranskat)abstract
    • AIM: The purpose of this study was to investigate the effects of carvedilol on diastolic function (DF) in heart failure patients with preserved left ventricular (LV) systolic function and abnormal DF. PATIENTS AND METHODS: We randomised 113 patients with diastolic heart failure (DHF) (symptomatic, with normal systolic LV function and abnormal DF) into a double blind multi-centre study. The patients received either carvedilol or matching placebo in addition to conventional treatment. After uptitration, treatment was continued for 6 months. Two-dimensional and Doppler echocardiography were used for quantification of LV function at baseline and at follow-up. Four different DF variables were evaluated by Doppler echocardiography: mitral flow E:A ratio, deceleration time (DT), isovolumic relaxation time (IVRT) and the ratio of systolic/diastolic pulmonary venous flow velocity (pv-S/D). Primary endpoint was change in the integrated quantitative assessment of all four variables during the study. RESULTS: Ninety-seven patients completed the study. A mitral flow pattern reflecting a relaxation abnormality was recorded in 95 patients. There was no effect on the primary endpoint, although a trend towards a better effect in carvedilol treated patients was noticed in patients with heart rates above 71 beats per minute. At the end of the study, there was a statistically significant improvement in E:A ratio in patients treated with carvedilol (0.72 to 0.83) vs. placebo (0.71 to 0.76), P<0.05. CONCLUSIONS: Treatment with carvedilol resulted in a significant improvement in E:A ratio in patients with heart failure due to a LV relaxation abnormality. E:A ratio was found to be the most useful variable to identify diastolic dysfunction in this patient population. This effect was observed particularly in patients with higher heart rates at baseline.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 67
Typ av publikation
tidskriftsartikel (62)
bokkapitel (3)
bok (1)
konferensbidrag (1)
Typ av innehåll
refereegranskat (62)
övrigt vetenskapligt/konstnärligt (5)
Författare/redaktör
Cardell, Lars-Olaf (4)
Willander, Magnus (3)
Tengvall, Pentti (3)
Wennergren, Göran, 1 ... (3)
Willander, Magnus, 1 ... (3)
Korhonen, Laura (2)
visa fler...
Lindholm, Dan (2)
Laginder, Ann-Marie, ... (2)
Ascher, Henry, 1953 (2)
Wang, X. (1)
Lindholm, P (1)
Ansell, Ricky (1)
Berglund, Lars (1)
Dellborg, Mikael, 19 ... (1)
Wigaeus Tornqvist, E ... (1)
Sandberg, Mats, 1953 (1)
Hedlund, R (1)
Andersson, G (1)
Mannervik, Bengt (1)
Welinder-Olsson, Chr ... (1)
Berne, Christian (1)
Sandberg, R (1)
Möller, Torgil (1)
Björk-Eriksson, Thom ... (1)
Seifert, Werner (1)
Samuelson, Lars (1)
Johansson, C. (1)
Persson, Clas (1)
Holmäng, Sten, 1954 (1)
Lindgren, F (1)
Marky, Ildiko, 1940 (1)
Olsson, M. (1)
Hagberg, Henrik, 195 ... (1)
Blomberg, Anders, 19 ... (1)
Karlsson, M (1)
Aspenberg, Per (1)
Rosen, Arne, 1939 (1)
Persson, H (1)
Janson, M (1)
Nilsson, M (1)
Pettersson, Håkan (1)
Sjövall, Henrik, 195 ... (1)
Lannering, Birgitta, ... (1)
Sun, Xiao-Feng, 1959 ... (1)
Swahn, Eva, 1949- (1)
Galaz, Victor (1)
Mattsson, Sören (1)
Sjödin, Helena (1)
Adner, Mikael (1)
Uddman, Rolf (1)
visa färre...
Lärosäte
Göteborgs universitet (67)
Karolinska Institutet (14)
Lunds universitet (11)
Uppsala universitet (8)
Chalmers tekniska högskola (8)
visa fler...
Umeå universitet (3)
Kungliga Tekniska Högskolan (2)
Högskolan i Halmstad (2)
Mälardalens universitet (1)
Örebro universitet (1)
Jönköping University (1)
Högskolan Dalarna (1)
visa färre...
Språk
Engelska (66)
Svenska (1)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (39)
Naturvetenskap (12)
Samhällsvetenskap (8)
Teknik (3)
År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy